| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050665044 |
| P356 | DOI | 10.1023/B:NEON.0000003679.40609.63 |
| P698 | PubMed publication ID | 14686728 |
| P2093 | author name string | Dietzmann K | |
| Kirches E | |||
| Kropf S | |||
| Mawrin C | |||
| Kanakis D | |||
| Dietzmann A | |||
| P2860 | cites work | Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity | Q28247147 |
| Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. | Q33614661 | ||
| Molecular effects of paclitaxel: myths and reality (a critical review). | Q33725219 | ||
| Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity | Q33911979 | ||
| Subcellular distribution of epothilones in human tumor cells | Q33944889 | ||
| Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. | Q34722347 | ||
| Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B. | Q36271699 | ||
| The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice | Q36541279 | ||
| BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy | Q43606278 | ||
| New taxanes and epothilone derivatives in clinical trials | Q43997123 | ||
| The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables | Q48483676 | ||
| Thermodynamics of ligand-induced assembly of tubulin. | Q52390474 | ||
| A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone | Q73816714 | ||
| P433 | issue | 2 | |
| P921 | main subject | cytoskeleton | Q154626 |
| P304 | page(s) | 99-106 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Nanomolar concentrations of epothilone D inhibit the proliferation of glioma cells and severely affect their tubulin cytoskeleton | |
| P478 | volume | 65 |
| Q28574198 | Epothilone D, a microtubule-stabilizing compound, inhibits neointimal hyperplasia after rat carotid artery injury by cell cycle arrest via regulation of G1-checkpoint proteins |
| Q37236419 | Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer |
| Q91603671 | G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future |
| Q37688393 | GBM-associated mutations and altered protein expression are more common in young patients |
| Q39214217 | Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies. |
| Q50239832 | Neurotransmitter noradrenaline downregulate cytoskeletal protein expression of VSMCs |
| Q36187046 | Novel therapeutics in adult malignant brain gliomas |
| Q37284300 | Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases |
| Q44092540 | Systemic sagopilone (ZK-EPO) treatment of patients with recurrent malignant gliomas. |
Search more.